COVAXIN COVID-19 vaccine

Adjuvant Developed with NIH Funding Enhances Efficacy of India’s COVID-19 Vaccine

An adjuvant developed with funding from the National Institutes of Health has contributed to the success of the highly efficacious COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere. Adjuvants are substances formulated… Read More ›